Nevus-associated melanomas: Clinicopathologic features

American Journal of Clinical Pathology

Volumn 142, Issue 4, 2014, Pages 485-491

  Shitara, Danielle ^a   Nascimento, Mauricio M ^a   Puig, Susana ^b,c   Yamada, Sérgio ^a   Enokihara, Milvia M S S ^a   Michalany, Nilceo ^a   Bagatin, Ediléia ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF BARCELONA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

Breslow; De novo melanoma; Histologic subtype; Nevus associated melanomas

Indexed keywords

ACRAL LENTIGINOUS MELANOMA; AMELANOTIC MELANOMA; ARTICLE; BRESLOW THICKNESS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; DESMOPLASTIC MELANOMA; DISEASE ASSOCIATION; FEMALE; FUSIFORM MELANOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MELANOMA; METASTASIS; NEVUS; NEVUS ASSOCIATED MELANOMA; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; SKIN BIOPSY; SKIN ULCER; SUN EXPOSURE; SUPERFICIAL SPREADING MELANOMA; ADVERSE EFFECTS; BRAZIL; INCIDENCE; NEVUS, PIGMENTED; PATHOLOGY; PROGNOSIS; SKIN NEOPLASMS; SUNLIGHT;

BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; NEVUS; NEVUS, PIGMENTED; PROGNOSIS; SKIN NEOPLASMS; SUNLIGHT;

EID: 84921672748     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP4L5CJGKTJVDD     Document Type: Article

References (42)

1. Geller AC, Annas GD. Epidemiology of melanoma and nonmelanoma skin cancer. Semin Oncol Nurs. 2003;19:2-11.
2. Giblin AV, Thomas JM. Incidence, mortality and survival in cutaneous melanoma. J Plast Reconstr Aesthetic Surg. 2007;60:32-40.
3. Anger M, Friedhofer H, Fukutaki M F, et al. Primary cutaneous melanoma: an 18-year study. Clinics (Sao Paulo). 2010;65:257-263.
4. INCA. Estimativa 2012 Instituto Nacional de Cancer 2012. http://www.inca.gov.br/estimativa/2012/index.asp?ID=5. Accessed August 22, 2014.
5. Chiba FB, Schettini A P, Delfino AC, et al. Clinical and epidemiological profile of cutaneous malignant melanomas in two referral institutions in the city of Manaus, Brazil. An Bras Dermatol. 2011;86:1239-1241.
6. Garbe C, Buttner P, Weiss J, et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol. 1994;102:695-699.
7. Nijsten T, Leys C, Verbruggen K, et al. Case-control study to identify melanoma risk factors in the Belgian population: the significance of clinical examination. J Eur Acad Dermatol Venereol. 2005;19:332-339.
8. Thomas NE, Groben P. Invasive superficial spreading melanomas arising from clinically normal skin. J Am Acad Dermatol. 2004;51:466-470.
9. Togawa Y, Nakamura Y, Kamada N, et al. Melanoma in association with acquired melanocytic nevus in Japan: a review of cases in the literature. Int J Dermatol. 2010;49:1362-1367.
10. Tsao H, Bevona C, Goggins W, et al. The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate. Arch Dermatol. 2003;139:282-288.
11. Echeverria B, Botella-Estrada R, Serra-Guillen C, et al. Increased risk of developing a second primary cutaneous nevus-associated melanoma in patients previously diagnosed with the disease [in Spanish]. Actas Dermosifiliogr. 2010;101:710-716.
12. Weatherhead SC, Haniffa M, Lawrence CM. Melanomas arising from naevi and de novo melanomas-does origin matter? Br J Dermatol. 2007;156:72-76.
13. Purdue MP, From L, Armstrong BK, et al. Etiologic and other factors predicting nevus-associated cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev. 2005;14:2015-2022.
14. Kaddu S, Smolle J, Zenahlik P, et al. Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis. Melanoma Res. 2002;12:271-278.
15. Crucioli V, Stilwell J. The histogenesis of malignant melanoma in relation to pre-existing pigmented lesions. J Cutan Pathol. 1982;9:396-404.
16. Skender-Kalnenas TM, English DR, Heenan PJ. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol. 1995;33:1000-1007.
17. Veronese LA, Corrente JE, Marques MEA. Melanoma maligno cutâneo: sistema de pontos (scoring system) para auxílio no diagnóstico histopatológico. J Bras Patol Med Lab. 2006;42:375-383.
18. Veronese LA, Corrente JE, Marques MEA. Critérios histopatológicos para diagnóstico de melanoma maligno cutâneo: análise comparativa de sua frequência em lesões benignas e melanomas de pequena espessura (<2mm). J Bras Patol Med Lab. 2007;43:363-368.
19. Barnhill R. Textbook of Dermatopathology. New York, NY: McGraw-Hill; 1998.
20. Stadler R, Garbe C. Nevus associated malignant melanomas-diagnostic validation and prognosis [in German]. Hautarzt. 1991;42:424-429.
21. McNutt NS. "Triggered trap": nevoid malignant melanoma. Semin Diagn Pathol. 1998;15:203-209.
22. McCullagh P, Nelder JA. Generalized Linear Models. New York, NY: Chapman & Hall; 1989.
23. Naser N. Cutaneous melanoma: a 30-year-long epidemiological study conducted in a city in southern Brazil, from 1980-2009. An Bras Dermatol. 2011;86:932-941.
24. Whiteman DC, Watt P, Purdie DM, et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst. 2003;95:806-812.
25. Cohen LM. Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol. 1995;33:923-940.
26. Carli P, Massi D, Santucci M, et al. Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study. J Am Acad Dermatol. 1999;40:549-557.
27. Massi D, Carli P, Franchi A, et al. Naevus-associated melanomas: cause or chance? Melanoma Res. 1999;9:85-91.
28. Whiteman DC, Parsons PG, Green AC. p53 expression and risk factors for cutaneous melanoma: a case-control study. Int J Cancer. 1998;77:843-848.
29. Gruber SB, Barnhill RL, Stenn KS, et al. Nevomelanocytic proliferations in association with cutaneous malignant melanoma: a multivariate analysis. J Am Acad Dermatol. 1989;21(pt 1):773-780.
30. Marks R, Dorevitch AP, Mason G. Do all melanomas come from "moles"? a study of the histological association between melanocytic naevi and melanoma. Australas J Dermatol. 1990;31:77-80.
31. Whiteman DC, Pavan WJ, Bastian BC. The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin. Pigment Cell Melanoma Res. 2011;24:879-897.
32. Greenwald HS, Friedman EB, Osman I. Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model. Melanoma Res. 2012;22:1-8.
33. Takata M, Murata H, Saida T. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma. Pigment Cell Melanoma Res. 2010;23:64-71.
34. Sagebiel RW. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness. J Invest Dermatol. 1993;100:322S-325S.
35. Garcia-Cruz A, Florez A, de la Torre-Fraga C, et al. Observational cross-sectional study comparing Breslow thickness of melanoma arising from naevi and melanoma de novo. Br J Dermatol. 2009;161:700-702.
36. Harley S, Walsh N. A new look at nevus-associated melanomas. Am J Dermatopathol. 1996;18:137-141.
37. Ackerman AB. What naevus is dysplastic, a syndrome and the commonest precursor of malignant melanoma? a riddle and an answer. Histopathology. 1988;13:241-256.
38. Consensus conference: precursors to malignant melanoma. JAMA. 1984;251:1864-1866.
39. Clark WH Jr, Elder DE, Guerry DT, et al. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol. 1984;15:1147-1165.
40. Barnhill RL, Cerroni L, Cook M, et al. State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop. Adv Anat Pathol. 2010;17:73-90.
41. Vollmer RT, Seigler H F. Using a continuous transformation of the Breslow thickness for prognosis in cutaneous melanoma. Am J Clin Pathol. 2001;115:205-212.
42. Barnhill RL, Fine JA, Roush GC, et al. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer. 1996;78:427-432.